Latest Videos |view all videos
A new, first-in-humans clinical trial for hepatocellular carcinoma uses an “armored” CAR T-cell therapy designed to resist the hostile tumor microenvironment found in 77% of patients with this disease.
Meet the Team: Chelsea Peterson, DO
Now, as a member of the Transplant and Cellular Therapy team at Roswell Park, Chelsea Peterson, DO, is eager to see the continued evolution of cellular and CAR T-cell therapies for patients beyond just those with solid tumors.
Using Electricity, Not Heat, to Ablate Tumors and Reinvigorate the Immune System
Using pulsed electric field ablation for resectable tumors helps not only kill the cancerous cells but might reinvigorate a patient’s immune system to fight back against their cancers.
Classical Hematology and Supportive Care
Steven Ambrusko of Roswell Park Comprehensive Cancer Center is joined by David Kroll of Brigham and Women’s Hospital and Alok Khorana from the Cleveland Clinic to discuss classical hematology and supportive care for patients.
Alex Niu of Roswell Park Comprehensive Cancer Center and Matthew Mei from City of Hope discuss changes and challenges in the treatment of Hodgkin lymphoma.
Multiple Myeloma & Plasma Cell Disorders
Hamza Hasan from Roswell Park is joined by Jack Khouri from the Clevland Clinic to discuss new developments for treating multiple myeloma and plasma cell disorders.
Mantle Cell Lymphoma, Follicular Lymphoma, & Waldenstro?m’s Macroglobulinemia
Yucai Wang from the Mayo Clinic is joined by Julia Chavez from Moffitt Cancer Center, Brian Hill of the Cleveland Clinic and Carla Casulo from the University of Rochester Medical Center to discuss new changes in front-line management and ...
Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma
Matthew Cortese of Roswell Park Comprehensive Cancer Center leads a discussion about frontline management and treatment of relapsed/refractory chronic lymphocytic leukemia and small cell leukemia, joined by Micole Lamanna from Herbert ...